Rheumatology International

, 28:1117 | Cite as

The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia

  • Omer Faruk Sendur
  • Engin Tastaban
  • Yasemin TuranEmail author
  • Cevval Ulman
Original Article


We examined the association between serum trace elements and clinical findings such as number of sensitive tender points, severity of fatigue and functional status in patients with fibromyalgia (FM). Thirty-two patients diagnosed as having FM according to the ACR 1990 criteria and 32 normal healthy controls (NHC) were included in this study. The demographic data, disease duration, number of tender points and accompanying symptoms (fatigue, sleep disorders, headache, paresthesia, irritable bowel syndrome, sicca symptoms, Raynaud’s phenomena) of the patients were noted. Visual analog scale (10 cm) was implemented to estimate daily severity of pain and fatigue. Fibromyalgia impact questionnaire was used for functional assessment. Serum selenium (μg/dL) and serum zinc (μg/dL) levels were measured by atomic absorption spectrometer. Serum magnesium (mmol/L) level was measured by the original kits of Abbott Aeroset auto-analyzer. The mean age of patients in FM group and NHC were calculated as 42.9 (SD = 7.7) years and 41.3 (SD = 9.7) years, respectively. Serum levels of zinc (P = 0.001) and magnesium (P = 0.002) were significantly decreased by FM groups, whereas there was no considerable difference with selenium levels of both groups (P > 0.05). Association between serum zinc level and number of tender points (P = 0.008) and that between fatigue and magnesium level (P = 0.003) was found as meaningful. According to the results of this study, it was asserted that serum magnesium and zinc levels may play an important role in the pathophysiology of FM.


Fibromyalgia Selenium Zinc Magnesium Clinical findings 


  1. 1.
    Bennett RM (1997) The fibromyalgia syndrome. In: Kelley WN, Haris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders Company, Philadelphia, pp 511–519Google Scholar
  2. 2.
    Mease P (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75:6–21PubMedGoogle Scholar
  3. 3.
    Ozgocmen S (2006) New strategies in evaluation of therapeutic efficacy in fibromyalgia syndrome. Curr Pharm Des 12:67–71PubMedCrossRefGoogle Scholar
  4. 4.
    Bray TM, Bettger WJ (1990) The physiological role of zinc as an antioxidant. Free Radic Biol Med 8:281–291PubMedCrossRefGoogle Scholar
  5. 5.
    Forceville X (2006) Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 10:180PubMedCrossRefGoogle Scholar
  6. 6.
    Frassinetti S, Bronzetti G, Caltavuturo L, Cini M, Croce CD (2006) The role of zinc in life: a review. J Environ Pathol Toxicol Oncol 25:597–610PubMedGoogle Scholar
  7. 7.
    Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447–1454Google Scholar
  8. 8.
    Romano TJ, Stiller JW (1994) Magnesium deficiency in fibromyalgia syndrome. J Nutr Med 4:165–167CrossRefGoogle Scholar
  9. 9.
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRefGoogle Scholar
  10. 10.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  11. 11.
    Price DD, McGrath PA, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17:45–56PubMedCrossRefGoogle Scholar
  12. 12.
    Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMedGoogle Scholar
  13. 13.
    Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12PubMedCrossRefGoogle Scholar
  14. 14.
    Yunus MB, Raman KIUP, Raman KK (1988) Primary fibromyalgia syndrome and myofacial pain syndrome: clinical features and muscle pathology. Arch Phys Med Rehabil 69:451–454PubMedGoogle Scholar
  15. 15.
    Abraham GE, Flechas JD (1992) Management of fibromyalgia: rationale for the use of magnesium and malic acid. J Nutr Med 3:49–59CrossRefGoogle Scholar
  16. 16.
    Prescott E, Norregard J, Pedersen LR, Danneskiold SB, Bülow P (1992) Red blood cell magnesium and fibromyalgia. Scand J Rheumatol 94(31):154Google Scholar
  17. 17.
    Eisinger J, Plantamura A, Marie PA, Ayavou T (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7:285–288PubMedGoogle Scholar
  18. 18.
    Eisinger J (1998) Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 5:5–15CrossRefGoogle Scholar
  19. 19.
    Mocchegiani E (2007) Zinc and ageing: third zinc age conference. Immun Ageing 4(1):5PubMedCrossRefGoogle Scholar
  20. 20.
    Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11(3):131–135PubMedCrossRefGoogle Scholar
  21. 21.
    Ozgocmen S, Ozyurt H, Sogut S, Akyol O (2006) Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 26:585–559PubMedCrossRefGoogle Scholar
  22. 22.
    Maes M, Mihaylova I, De Ruyter M (2006) Lower serum zinc in chronic fatigue syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 90(2/3):141–147PubMedCrossRefGoogle Scholar
  23. 23.
    Hickie I, Lloyd A, Wakefield D, Parker G (1990) The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychol 156:534–540CrossRefGoogle Scholar
  24. 24.
    Meeus M, Nijs J (2007) Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26(4):465–473PubMedCrossRefGoogle Scholar
  25. 25.
    Rea HM, Thomson CD, Campbell DR, Robinson MF (1979) Relation between erythrocyte selenium concentrations and glutathione peroxidase (EC activities of New Zealand residents and visitors to New Zealand. Br J Nutr 42(2):201–208PubMedCrossRefGoogle Scholar
  26. 26.
    Reinhard P, Schweinsberg F, Wernet D, Kotter I (1998) Selenium status in fibromyalgia. Toxicol Lett 96–97:177–180PubMedCrossRefGoogle Scholar
  27. 27.
    Flodin NW (1988) Pharmacology of micronutrients. Alan R. Liss, New YorkGoogle Scholar
  28. 28.
    Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM (1983) Clinical characteristics of fibrositis. I. A “blinded”, controlled study of symptoms and tender points. Arthritis Rheum 26:817–824PubMedCrossRefGoogle Scholar
  29. 29.
    Wallace DJ (1997) The fibromyalgia syndrome. Ann Med 29:9–21PubMedCrossRefGoogle Scholar
  30. 30.
    White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26:1577–1585PubMedGoogle Scholar
  31. 31.
    Keenoy BM, Moorkens G, Vertommen J, Noe M, Neve J, De Leeuw I (2000) Magnesium status and parameters of the oxidant–antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19(3):374–382Google Scholar
  32. 32.
    Clague JE, Edwards RHT, Jackson MJ (1992) Intravenous magnesium loading in chronic fatigue syndrome. Lancet 340:124–125PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Omer Faruk Sendur
    • 1
  • Engin Tastaban
    • 1
  • Yasemin Turan
    • 1
    • 3
    Email author
  • Cevval Ulman
    • 2
  1. 1.Department of Physical Medicine and RehabilitationAdnan Menderes University Medicine School HospitalAydinTurkey
  2. 2.Department of BiochemistryCelal Bayar University Medicine School HospitalManisaTurkey
  3. 3.IzmirTurkey

Personalised recommendations